Trademark Overview
On Tuesday, May 2, 2023, a trademark application was filed for CAREEFFECTS with the United States Patent and Trademark Office. The USPTO has given the CAREEFFECTS trademark a serial number of 97916759. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Indicator Sciences, LLC. The CAREEFFECTS trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Consultative analytics services namely the collection, reporting, and analysis of healthcare quality data that employs comprehensive, context-of-care risk adjustment to identify individual nurses whose practices significantly impact patient outcomes or treatment; Consultative analytics services namely collection, reporting, and analysis of healthcare quality data that employs comprehensive, context- of-care risk adjustment to identify caregivers whose practices significantly impact opioid or benzodiazepine utilization for reducing excess opioid and benzodiazepine use and improving patient outcomes in hospitals
Medical analysis services relating to the treatment of patients; Providing information and analysis in the fields of nursing, patient outcomes and medication administration; Consultative services in the nature of identifying individual nurses whose practices significantly impact patient outcomes or treatment; Consultative services in the nature of opioid or benzodiazepine utilization, reducing excess opioid and benzodiazepine use and improving patient outcomes in hospitals
Software as a service (SAAS) services featuring software for analyzing patient treatment and patient outcome data; Software as a service (SAAS) services featuring software for analyzing nursing data; Software as a service (SAAS) services featuring software for analyzing patient medication administration data; Software as a service (SAAS) services featuring software identifying individual nurses whose practices significantly impact patient outcomes or treatment; Software as a service (SAAS) services featuring software identifying individual care givers whose practices significantly impact patient opioid or benzodiazepine utilization for reducing excess opioid and benzodiazepine use and improving patient outcomes in hospitals